Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & molecular medicine, 2022 - nature.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

M Labrie, JS Brugge, GB Mills… - Nature reviews Cancer, 2022 - nature.com
Normal cells explore multiple states to survive stresses encountered during development
and self-renewal as well as environmental stresses such as starvation, DNA damage, toxins …

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning

SA Langhans - Frontiers in pharmacology, 2018 - frontiersin.org
Drug development is a lengthy and costly process that proceeds through several stages
from target identification to lead discovery and optimization, preclinical validation and …

Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative

Q Song, B Bates, YR Shao, FC Hsu, F Liu… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

JK Hwang, T Zhang, AZ Wang, Z Li - Journal of hematology & oncology, 2021 - Springer
Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-
2 have been approved for at least limited use, with over sixty others in clinical trials. This …

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

K Pandey, HJ An, SK Kim, SA Lee… - … journal of cancer, 2019 - Wiley Online Library
Deregulation of the cyclin D‐CDK4/6‐INK4‐RB pathway leading to uncontrolled cell
proliferation, is frequently observed in breast cancer. Currently, three selective CDK4/6 …

New advances in the research of resistance to neoadjuvant chemotherapy in breast cancer

J An, C Peng, H Tang, X Liu, F Peng - International journal of molecular …, 2021 - mdpi.com
Breast cancer has an extremely high incidence in women, and its morbidity and mortality
rank first among female tumors. With the increasing development of medicine today, the …

An update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations

B Kantarcioglu, O Iqbal, J Lewis… - Clinical and Applied …, 2022 - journals.sagepub.com
The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia

X Wang, C Chen, D Vuong, S Rodriguez-Rodriguez… - Leukemia, 2023 - nature.com
Neddylation is a sequential enzyme-based process which regulates the function of E3 Cullin-
RING ligase (CRL) and thus degradation of substrate proteins. Here we show that CD8+ T …

Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response

SP Korpela, TK Hinz, A Oweida, J Kim… - Journal of translational …, 2021 - Springer
Background Epidermal growth factor receptor (EGFR) is frequently amplified or
overexpressed in head and neck squamous cell carcinoma (HNSCC) and is a clinically …